1182. The Real-World Use of Isavuconazole as Primary or salvage Therapy of Invasive Fungal infections in High-Risk Patients with Hematologic Malignancy or Stem Cell Transplant

BACKGROUND: Invasive fungal infections (IFIs) are a major cause of morbidity and mortality among immunocompromised patients with hematologic malignancies (HM) and stem cell transplants (SCT). Isavuconazole was approved by FDA as a primary therapy for Invasive Aspergillosis (IA) and Mucormycosis. The...

Descripción completa

Detalles Bibliográficos
Autores principales: dagher, Hiba, Hachem, Ray Y, Chaftari, Anne-Marie, Jiang, Ying, Ali, Shahnoor, Deeba, Rita, Shah, Shivan, Raad, Issam I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776545/
http://dx.doi.org/10.1093/ofid/ofaa439.1368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776545/
http://dx.doi.org/10.1093/ofid/ofaa439.1368

Ejemplares similares